ADHD and SUD in Calabasas

What This Treatment Is

ADHD (attention-deficit/hyperactivity disorder) and substance use disorder co-occur at significantly elevated rates. Peer-reviewed epidemiologic research suggests roughly 25% of adults with SUD also have ADHD — several times the general-population rate. Untreated ADHD in adulthood is a well-documented risk factor for SUD, likely because impulsivity, executive dysfunction, and self-medication with stimulants create pathways into problematic substance use.

Why the Comorbidity Exists

ADHD involves difficulties with sustained attention, impulse control, and executive function. These features increase vulnerability to substance use in several ways: impulsive experimentation, difficulty stopping once started, self-medication of attention or arousal problems with stimulants or alcohol, and difficulty maintaining the structure that supports recovery. Treating the ADHD directly reduces some of the biological drivers of substance use.

Treatment Considerations

ADHD in co-occurring SUD requires careful medication decisions. Non-stimulant options — atomoxetine, guanfacine, viloxazine, bupropion — are often considered first because they carry no misuse potential. When stimulant treatment is indicated, extended-release formulations are preferred (Vyvanse, Concerta) because they have lower misuse potential than immediate-release preparations. Behavioral treatments — CBT for ADHD, coaching around organization and executive function — are core alongside medication.

Elevated Healing’s Specialty-Led Approach

For Calabasas patients, treatment happens at our Woodland Hills campus (~15 min via US-101). Our psychiatric team is experienced in adult ADHD assessment and understands the specific complications of stimulant prescribing in co-occurring SUD.

Practically:

• Full psychiatric evaluation including ADHD assessment (structured screening, symptom history since childhood, functional impairment).
• SUD evaluation with attention to whether stimulants or alcohol have been self-medicated for attention or arousal.
• Non-stimulant first-line consideration: atomoxetine, guanfacine, viloxazine, or bupropion.
• Stimulant treatment with extended-release preparations if clinically indicated and SUD is stable.
• CBT for ADHD focused on organization, planning, and executive function skills.
• MAT for co-occurring alcohol or opioid use disorder.
• Most follow-up psychiatric visits eligible for telehealth for California residents.

Access from Calabasas

Our physical location is at 21250 Califa St, Ste 114, Woodland Hills, CA 91367, about a 15-minute drive from Calabasas via US-101 in normal traffic.

• From central Calabasas — US-101 East, exit at Winnetka Avenue or De Soto Avenue, then a short drive north.
• From Hidden Hills or Woodland Hills-adjacent areas — many patients complete the trip in under 15 minutes.
• From Agoura Hills or Westlake Village — allow about 20–25 minutes via US-101.
• Telehealth — after your initial in-person assessment, most follow-up psychiatric visits can be done by video across California, reducing travel burden for maintenance and step-down care.

New patients typically complete their initial evaluation in person; ongoing follow-up can be scheduled remotely when clinically appropriate.

Program Levels That Deliver This Care

This service is delivered inside the level of care that matches your clinical need at intake. Level of care can shift over time as treatment progresses.

Insurance, Cost, and Getting Started

Most commercial insurance plans cover adhd and sud under mental health and substance use disorder benefits, which are subject to federal parity requirements under the Mental Health Parity and Addiction Equity Act. Parity means insurers cannot impose stricter limits on behavioral health services than they apply to physical health services — a real legal protection worth knowing you have when you call.

The first step is a conversation with our admissions team. This call is free, confidential, and carries no obligation. During it, we:

• Verify your insurance benefits within one business day.
• Confirm what’s covered, what your copay or coinsurance will be, and whether prior authorization applies.
• Start any required prior authorization on your behalf so you’re not stuck on hold with your insurer.
• Schedule a clinical evaluation — usually within a few business days of your first call, sooner when the situation is time-sensitive.

If insurance doesn’t cover the service or your plan design doesn’t fit, self-pay options can be discussed. There is no charge to have this conversation. Reach us at (747) 888-3000 or use our insurance verification form.

What Progress Looks Like

Recovery through adhd and sud is not a straight line, and durable clinical outcomes rarely happen in weeks. Realistic timelines matter here more than optimistic promises. Most patients notice measurable improvement in the first month of consistent treatment — reduced cravings, more stable mood, better sleep, easier engagement with therapy. Substantive behavioral change typically takes root over three to six months.

Progress is reviewed at every clinical visit. We measure it in specifics: frequency of the target behavior, functional recovery in work and relationships, sleep quality, and — where medications are involved — how well the pharmacology is holding cravings and side effects. When something isn’t working, we adjust. That might mean a dose change, a therapy focus shift, or a step up or down in level of care. The plan follows the patient’s clinical picture, not the other way around.

Setbacks are treated as clinical data, not moral failure. If a relapse or symptom flare happens, the team’s job is to understand what led to it and refine the plan. Patients are not discharged for a relapse. Long-term recovery is often what happens after the acute treatment phase ends, and we plan for that from the first visit — through aftercare planning, coordinated hand-offs, and telehealth follow-up available across California.

Confidentiality and HIPAA Protections

Treatment records at Elevated Healing are protected under the Health Insurance Portability and Accountability Act (HIPAA) and, for substance use records specifically, under 42 CFR Part 2 — a federal regulation providing additional protection for substance use disorder treatment information. That means treatment status and clinical details are not disclosed to family members, employers, or third parties without your written authorization, except in narrowly defined legal circumstances (imminent harm, court order).

Practical protections include HIPAA-compliant scheduling and communication systems, secure insurance verification channels, and billing structured to minimize what appears on statements. Patients with heightened confidentiality concerns can request specific accommodations at intake — arrival timing, check-in flow, telehealth-first scheduling — and our admissions team will confirm what’s available.

Frequently Asked Questions